Abstract LB520: A pharmacodynamic platform using liquid biopsy to support dose selection for the ATR inhibitor ART0380 (IACS-030380)Manish R. Patel, Melissa M. Johnson, Kathleen N. Moore et al.|Cancer Research|2022Cited by 3
Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Barzin Y. Nabet et al.|Cancer Research|2023Cited by 0